Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study
2020 ◽
Vol 83
(1)
◽
pp. 96-103
◽
Keyword(s):